Citi has some stocks that could see upside even as the U.S.-Iran war weighs on Wall Street. The weekslong Middle East conflict has been worrying investors and pushing oil prices higher. The S & P 500 has dropped nearly 8% in March, on track for its worst monthly performance since 2022. Citi analyst Richard Schlatter sought stocks that can sidestep recent volatility. From there, he looked for picks that could have positive catalysts on the horizon. To do this, Schlatter overlaid the crowding composites tracked by Citi. He sorted for stocks that have upside catalysts that aren’t relatively crowded and thus could see a positive reaction to fundamental tailwinds. Here are five names that made the list: Delta Air Lines turned up in the search, with the stock down only 3.8% this month. Shares of the air carrier have dropped nearly 9% in 2026, on track to snap a three-year win streak. Wall Street expects a rebound ahead: The average analyst polled by LSEG has a buy rating and a price target implying the stock can gain roughly 25% over the next year. Summit Therapeutics also made Citi’s list. The stock, up 2.4% since the war began, has long crowding composite of just 18.1%, the bank said. Analysts in general are bullish on the stock. Of the 18 who cover it, 13 rate it a buy or strong buy, LSEG data shows.
